Vivera expanded ts license for TABMELT technology to Israel, the company announced. TABMELT provides sublingual drug delivery.
The sublingual delivery route may lead to more instantaneous and accurate absorption than oral drug delivery for specific drugs because it largely bypasses the GI tract and first-pass metabolism in the liver, both significant sites of oral drug metabolism. Many patients struggle to take their medications due to unfavorable side effects or difficulty swallowing. Sublingualmdrug delivery routes are designed to reduce these barriers and may make it easier for patients to adhere to their medication regimens.